A detailed history of Four Thought Financial, LLC transactions in Haemonetics Corp stock. As of the latest transaction made, Four Thought Financial, LLC holds 1,113 shares of HAE stock, worth $87,259. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,113
Previous 1,113 -0.0%
Holding current value
$87,259
Previous $73,000 12.33%
% of portfolio
0.01%
Previous 0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

BUY
$49.27 - $66.08 $4,729 - $6,343
96 Added 9.44%
1,113 $73,000
Q1 2022

Apr 29, 2022

BUY
$43.77 - $63.22 $4,201 - $6,069
96 Added 10.42%
1,017 $64,000
Q3 2021

Nov 12, 2021

BUY
$57.6 - $70.59 $29,260 - $35,859
508 Added 123.0%
921 $65,000
Q2 2021

Nov 12, 2021

SELL
$51.81 - $118.56 $621 - $1,422
-12 Reduced 2.82%
413 $27,000
Q1 2021

Nov 12, 2021

SELL
$111.01 - $139.48 $3,108 - $3,905
-28 Reduced 6.18%
425 $47,000
Q4 2020

Nov 12, 2021

BUY
$88.75 - $119.95 $40,203 - $54,337
453 New
453 $53,000

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $4.02B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Four Thought Financial, LLC Portfolio

Follow Four Thought Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Four Thought Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Four Thought Financial, LLC with notifications on news.